ArticleJournal of medicine and life2023
Predicting perinatal outcomes in women affected by COVID-19: An artificial intelligence (AI) approach.
Article in Journal of medicine and life, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 1 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to explore the role of artificial intelligence (AI) in predicting perinatal outcomes among women with COVID-19. Data was collected from hospitals in the Middle Euphrates and Southern regions of Iraq, with 152 pregnant patients included in the study. Patients were categorized into mild and severe infection groups, and their serum samples were analyzed for mineral levels (magnesium, copper, calcium, sodium, potassium, zinc, selenium, and iron) and immune factors (IL-6, IL-8, IL-32, IL-10, IL-18, IL-37, IL-38, IL-36, and IL-1). The findings revealed significant associations between specific mineral levels, immune factors, and perinatal outcomes. Mineral levels such as magnesium (75.5% mild infection, 80.9% severe infection), copper (68.2% mild infection, 64.3% severe infection), calcium ion (81.8% mild infection, 76.2% severe infection), sodium (70.9% mild infection, 69.0% severe infection), potassium (72.7% mild infection, 71.4% severe infection), zinc (61.8% mild infection, 54.8% severe infection), selenium (78.2% mild infection, 82.9% severe infection), and iron (74.5% mild infection, 68.3% severe infection) showed varying percentages associated with mild and severe infections. Immune factors such as IL-6 (32% mild infection, 21% severe infection), IL-8 (15% mild infection, 7% severe infection), IL-32 (24% mild infection, 9% severe infection), IL-10 (7% mild infection, no severe infection), IL-18 (13% mild infection, 11% severe infection) demonstrated varying percentages associated with perinatal outcomes, while other interleukins showed no changes in severe infections. These results highlight the potential of AI in predicting outcomes for pregnant women with COVID-19, which could aid in improving their management and care. Further research and validation of predictive models are recommended to enhance accuracy and applicability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.